From: Development and validation of the openness to the future scale: a prospective protective factor
Clinical Population Mean (SD) | General Population Mean (SD) | t | p | Cohen’s d [95% CI] | |
---|---|---|---|---|---|
OFS | 32.29 (7.93) | 39.02 (4.95) | 15.85 | <.001 | −1.11 [− 1.23, −.99] |
BHS | 7.62 (5.91) | 3.54 (3.22) | −9.64 | <.001 | .96 [.83, 1.08] |
PSWQ | 60.31 (12.11) | 50.54 (13) | −7.86 | <.001 | .77 [.65, .89] |
ODSIS | 7.89 (5.37) | 3.73 (4.13) | −8.32 | <.001 | .91 [.79, 1.03] |
OASIS | 9.66 (4.98) | 5.02 (4.07) | −13.6 | <.001 | 1.06 [.93, 1.18] |
RSES | 1.42 (0.93) | 2.2 (0.72) | 9.04 | <.001 | −.98 [−1.11, −.86] |
GSES | 27.07 (8.5) | 33.17 (6.55) | 9.88 | <.001 | −.84 [−.96, −.72] |
LOT-R | 16.02 (4.11) | 20.65 (4.5) | 7.05 | <.001 | −1.06 [−1.18, −.93] |
PANAS-P | 25.81 (8.82) | 34.23 (7.24) | 13.99 | <.001 | −1.08 [− 1.21, −.96] |
PANAS-N | 26.62 (8.61) | 19.37 (6.85) | −12.41 | <.001 | .97 [.85, 1.10] |
SPT-POS | 41.79 (10.65) | 50.18 (9.21) | 9.7 | <.001 | −.86 [−.99, −.74] |
SPT-NEG | 77.53 (27.4) | 67.53 (21.88) | −4.57 | <.001 | .42 [.30, .54] |
BP-SA | 5.18 (1.62) | 5.8 (1.43) | 4.41 | <.001 | −.41 [−.53, −.30] |
BP-PR | 4.19 (1.32) | 4.87 (1.01) | 5.65 | <.001 | −.61 [−.73, −.49] |
BP-EM | 3.61 (1.08) | 4.34 (.87) | 7.35 | <.001 | −.77 [−.89, −.65] |
BP-A | 3.67 (1.08) | 4.4 (.94) | 7.85 | <.001 | −.74 [−.86, −.62] |
BP-PG | 4.35 (1.28) | 5.04 (.8) | 5.96 | <.001 | .70 [−.82, −.59] |
BP-PL | 3.65 (1.32) | 4.73 (.92) | 9.08 | <.001 | −1.01 [−1.14, −.89] |